Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reimer, P.
Right arrow Articles by Wittenberg, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reimer, P.
Right arrow Articles by Wittenberg, J.

Radiology, Vol 180, 641-645, Copyright © 1991 by Radiological Society of North America

ARTICLES

Experimental hepatocellular carcinoma: MR receptor imaging

P Reimer, R Weissleder, TJ Brady, AE Yeager, BH Baldwin, BC Tennant and J Wittenberg
MGH-NMR Center, Charlestown, MA 02129.

Relaxation time measurements and magnetic resonance (MR) imaging were performed in three different animal models of hepatocellular carcinoma (HCC). After intravenous administration of asialoglycoprotein-directed arabinogalactan-stabilized ultrasmall superparamagnetic iron oxide (10 mumol Fe/kg receptor agent), T2 of normal liver decreased from 41.6 msec +/- 1.0 to 19.4 msec +/- 1.7 (P less than .05) in rats. T2 of HCC implanted in normal liver or liver with chronic hepatitis was essentially unchanged. These results were similar to those obtained by administration of a reticuloendothelial cell-directed conventional iron oxide; however, the required dose of receptor agent was lower. MR imaging in a woodchuck model of virally induced HCC confirmed the distribution of the hepatocyte-directed agent to regions of functioning and differentiated hepatocytes but not to malignant tumor tissue. The results suggest that MR receptor imaging may play a role in the differentiation between primary liver tumor and functional liver tissue such as that in normal liver hepatitis or regenerating nodules.


This article has been cited by other articles:


Home page
 RadiologyHome page
R. R. Edelman
Contrast-enhanced MR Imaging of the Heart: Overview of the Literature
Radiology, September 1, 2004; 232(3): 653 - 668.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Luciani, J.-C. Olivier, O. Clement, N. Siauve, P.-Y. Brillet, B. Bessoud, F. Gazeau, I. F. Uchegbu, E. Kahn, G. Frija, et al.
Glucose-Receptor MR Imaging of Tumors: Study in Mice with PEGylated Paramagnetic Niosomes
Radiology, April 1, 2004; 231(1): 135 - 142.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1991 by the Radiological Society of North America.